JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=588630, encodeId=63795886305e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/cbfea1f3df096eb4de0421ec39551f1c.jpg, createdBy=bf172153584, createdName=羽和, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587554, encodeId=9fa758e554e9, content=3-26accepted454646258 2020-03-11 发表:: 刚修回去454646258 2020-03-11 00:00:00 发表: 刚修回去, beContent=454646258 2020-03-11 发表:: 刚修回去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586551, encodeId=70ef586551c6, content=请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表: 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, beContent=Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584398, encodeId=99ee5843988d, content=@454646258，你的结果怎么样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0988102009, createdName=fangfang424, createdTime=Sat Feb 08 08:53:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582347, encodeId=a69458234e78, content=非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578681, encodeId=2fdc5e868165, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570775, encodeId=920b5e0775cf, content=我2月26投的稿，今天5月11日，依然under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Sat May 11 20:22:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569918, encodeId=a2cb5699187c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ad15083627, createdName=lan2012172_76943970, createdTime=Tue Apr 23 09:56:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569152, encodeId=40445691524c, content=5.789, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3bd1650194, createdName=kexueren, createdTime=Fri Apr 05 08:01:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850297, encodeId=cbde85029ede, content=18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题； 补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。 19.1.31接收。 提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Mon Mar 18 10:09:59 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2020-04-11 羽和

审稿速度:1.0 | 投稿命中率:25.0
经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept

211 0

[GetPortalCommentsPageByObjectIdResponse(id=588630, encodeId=63795886305e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/cbfea1f3df096eb4de0421ec39551f1c.jpg, createdBy=bf172153584, createdName=羽和, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587554, encodeId=9fa758e554e9, content=3-26accepted454646258 2020-03-11 发表:: 刚修回去454646258 2020-03-11 00:00:00 发表: 刚修回去, beContent=454646258 2020-03-11 发表:: 刚修回去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586551, encodeId=70ef586551c6, content=请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表: 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, beContent=Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584398, encodeId=99ee5843988d, content=@454646258，你的结果怎么样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0988102009, createdName=fangfang424, createdTime=Sat Feb 08 08:53:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582347, encodeId=a69458234e78, content=非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578681, encodeId=2fdc5e868165, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570775, encodeId=920b5e0775cf, content=我2月26投的稿，今天5月11日，依然under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Sat May 11 20:22:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569918, encodeId=a2cb5699187c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ad15083627, createdName=lan2012172_76943970, createdTime=Tue Apr 23 09:56:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569152, encodeId=40445691524c, content=5.789, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3bd1650194, createdName=kexueren, createdTime=Fri Apr 05 08:01:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850297, encodeId=cbde85029ede, content=18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题； 补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。 19.1.31接收。 提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Mon Mar 18 10:09:59 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2020-03-27 454646258

3-26accepted454646258 2020-03-11 发表::
刚修回去454646258 2020-03-11 00:00:00 发表:
刚修回去

454646258 2020-03-11 发表:: 刚修回去

187 0

[GetPortalCommentsPageByObjectIdResponse(id=588630, encodeId=63795886305e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/cbfea1f3df096eb4de0421ec39551f1c.jpg, createdBy=bf172153584, createdName=羽和, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587554, encodeId=9fa758e554e9, content=3-26accepted454646258 2020-03-11 发表:: 刚修回去454646258 2020-03-11 00:00:00 发表: 刚修回去, beContent=454646258 2020-03-11 发表:: 刚修回去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586551, encodeId=70ef586551c6, content=请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表: 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, beContent=Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584398, encodeId=99ee5843988d, content=@454646258，你的结果怎么样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0988102009, createdName=fangfang424, createdTime=Sat Feb 08 08:53:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582347, encodeId=a69458234e78, content=非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578681, encodeId=2fdc5e868165, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570775, encodeId=920b5e0775cf, content=我2月26投的稿，今天5月11日，依然under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Sat May 11 20:22:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569918, encodeId=a2cb5699187c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ad15083627, createdName=lan2012172_76943970, createdTime=Tue Apr 23 09:56:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569152, encodeId=40445691524c, content=5.789, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3bd1650194, createdName=kexueren, createdTime=Fri Apr 05 08:01:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850297, encodeId=cbde85029ede, content=18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题； 补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。 19.1.31接收。 提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Mon Mar 18 10:09:59 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2020-03-13 454646258

请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表::
研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表:
刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。

Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。

180 0

[GetPortalCommentsPageByObjectIdResponse(id=588630, encodeId=63795886305e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/cbfea1f3df096eb4de0421ec39551f1c.jpg, createdBy=bf172153584, createdName=羽和, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587554, encodeId=9fa758e554e9, content=3-26accepted454646258 2020-03-11 发表:: 刚修回去454646258 2020-03-11 00:00:00 发表: 刚修回去, beContent=454646258 2020-03-11 发表:: 刚修回去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586551, encodeId=70ef586551c6, content=请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表: 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, beContent=Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584398, encodeId=99ee5843988d, content=@454646258，你的结果怎么样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0988102009, createdName=fangfang424, createdTime=Sat Feb 08 08:53:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582347, encodeId=a69458234e78, content=非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578681, encodeId=2fdc5e868165, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570775, encodeId=920b5e0775cf, content=我2月26投的稿，今天5月11日，依然under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Sat May 11 20:22:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569918, encodeId=a2cb5699187c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ad15083627, createdName=lan2012172_76943970, createdTime=Tue Apr 23 09:56:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569152, encodeId=40445691524c, content=5.789, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3bd1650194, createdName=kexueren, createdTime=Fri Apr 05 08:01:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850297, encodeId=cbde85029ede, content=18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题； 补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。 19.1.31接收。 提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Mon Mar 18 10:09:59 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2020-02-08 fangfang424

@454646258，你的结果怎么样了？

150 0

[GetPortalCommentsPageByObjectIdResponse(id=588630, encodeId=63795886305e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/cbfea1f3df096eb4de0421ec39551f1c.jpg, createdBy=bf172153584, createdName=羽和, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587554, encodeId=9fa758e554e9, content=3-26accepted454646258 2020-03-11 发表:: 刚修回去454646258 2020-03-11 00:00:00 发表: 刚修回去, beContent=454646258 2020-03-11 发表:: 刚修回去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586551, encodeId=70ef586551c6, content=请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表: 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, beContent=Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584398, encodeId=99ee5843988d, content=@454646258，你的结果怎么样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0988102009, createdName=fangfang424, createdTime=Sat Feb 08 08:53:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582347, encodeId=a69458234e78, content=非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578681, encodeId=2fdc5e868165, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570775, encodeId=920b5e0775cf, content=我2月26投的稿，今天5月11日，依然under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Sat May 11 20:22:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569918, encodeId=a2cb5699187c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ad15083627, createdName=lan2012172_76943970, createdTime=Tue Apr 23 09:56:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569152, encodeId=40445691524c, content=5.789, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3bd1650194, createdName=kexueren, createdTime=Fri Apr 05 08:01:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850297, encodeId=cbde85029ede, content=18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题； 补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。 19.1.31接收。 提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Mon Mar 18 10:09:59 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2019-12-29 454646258

非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers

121 0

[GetPortalCommentsPageByObjectIdResponse(id=588630, encodeId=63795886305e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/cbfea1f3df096eb4de0421ec39551f1c.jpg, createdBy=bf172153584, createdName=羽和, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587554, encodeId=9fa758e554e9, content=3-26accepted454646258 2020-03-11 发表:: 刚修回去454646258 2020-03-11 00:00:00 发表: 刚修回去, beContent=454646258 2020-03-11 发表:: 刚修回去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586551, encodeId=70ef586551c6, content=请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表: 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, beContent=Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584398, encodeId=99ee5843988d, content=@454646258，你的结果怎么样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0988102009, createdName=fangfang424, createdTime=Sat Feb 08 08:53:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582347, encodeId=a69458234e78, content=非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578681, encodeId=2fdc5e868165, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570775, encodeId=920b5e0775cf, content=我2月26投的稿，今天5月11日，依然under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Sat May 11 20:22:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569918, encodeId=a2cb5699187c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ad15083627, createdName=lan2012172_76943970, createdTime=Tue Apr 23 09:56:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569152, encodeId=40445691524c, content=5.789, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3bd1650194, createdName=kexueren, createdTime=Fri Apr 05 08:01:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850297, encodeId=cbde85029ede, content=18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题； 补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。 19.1.31接收。 提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Mon Mar 18 10:09:59 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

求经验求分享

126 0

[GetPortalCommentsPageByObjectIdResponse(id=588630, encodeId=63795886305e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/cbfea1f3df096eb4de0421ec39551f1c.jpg, createdBy=bf172153584, createdName=羽和, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587554, encodeId=9fa758e554e9, content=3-26accepted454646258 2020-03-11 发表:: 刚修回去454646258 2020-03-11 00:00:00 发表: 刚修回去, beContent=454646258 2020-03-11 发表:: 刚修回去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586551, encodeId=70ef586551c6, content=请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表: 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, beContent=Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584398, encodeId=99ee5843988d, content=@454646258，你的结果怎么样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0988102009, createdName=fangfang424, createdTime=Sat Feb 08 08:53:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582347, encodeId=a69458234e78, content=非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578681, encodeId=2fdc5e868165, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570775, encodeId=920b5e0775cf, content=我2月26投的稿，今天5月11日，依然under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Sat May 11 20:22:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569918, encodeId=a2cb5699187c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ad15083627, createdName=lan2012172_76943970, createdTime=Tue Apr 23 09:56:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569152, encodeId=40445691524c, content=5.789, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3bd1650194, createdName=kexueren, createdTime=Fri Apr 05 08:01:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850297, encodeId=cbde85029ede, content=18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题； 补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。 19.1.31接收。 提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Mon Mar 18 10:09:59 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2019-05-11 lucifer11

我2月26投的稿，今天5月11日，依然under review

140 0

[GetPortalCommentsPageByObjectIdResponse(id=588630, encodeId=63795886305e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/cbfea1f3df096eb4de0421ec39551f1c.jpg, createdBy=bf172153584, createdName=羽和, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587554, encodeId=9fa758e554e9, content=3-26accepted454646258 2020-03-11 发表:: 刚修回去454646258 2020-03-11 00:00:00 发表: 刚修回去, beContent=454646258 2020-03-11 发表:: 刚修回去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586551, encodeId=70ef586551c6, content=请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表: 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, beContent=Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584398, encodeId=99ee5843988d, content=@454646258，你的结果怎么样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0988102009, createdName=fangfang424, createdTime=Sat Feb 08 08:53:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582347, encodeId=a69458234e78, content=非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578681, encodeId=2fdc5e868165, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570775, encodeId=920b5e0775cf, content=我2月26投的稿，今天5月11日，依然under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Sat May 11 20:22:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569918, encodeId=a2cb5699187c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ad15083627, createdName=lan2012172_76943970, createdTime=Tue Apr 23 09:56:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569152, encodeId=40445691524c, content=5.789, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3bd1650194, createdName=kexueren, createdTime=Fri Apr 05 08:01:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850297, encodeId=cbde85029ede, content=18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题； 补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。 19.1.31接收。 提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Mon Mar 18 10:09:59 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2019-04-23 lan2012172_76943970

审稿速度:2.0 | 投稿命中率:25.0
经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。

164 0

[GetPortalCommentsPageByObjectIdResponse(id=588630, encodeId=63795886305e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/cbfea1f3df096eb4de0421ec39551f1c.jpg, createdBy=bf172153584, createdName=羽和, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587554, encodeId=9fa758e554e9, content=3-26accepted454646258 2020-03-11 发表:: 刚修回去454646258 2020-03-11 00:00:00 发表: 刚修回去, beContent=454646258 2020-03-11 发表:: 刚修回去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586551, encodeId=70ef586551c6, content=请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表: 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, beContent=Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584398, encodeId=99ee5843988d, content=@454646258，你的结果怎么样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0988102009, createdName=fangfang424, createdTime=Sat Feb 08 08:53:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582347, encodeId=a69458234e78, content=非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578681, encodeId=2fdc5e868165, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570775, encodeId=920b5e0775cf, content=我2月26投的稿，今天5月11日，依然under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Sat May 11 20:22:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569918, encodeId=a2cb5699187c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ad15083627, createdName=lan2012172_76943970, createdTime=Tue Apr 23 09:56:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569152, encodeId=40445691524c, content=5.789, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3bd1650194, createdName=kexueren, createdTime=Fri Apr 05 08:01:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850297, encodeId=cbde85029ede, content=18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题； 补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。 19.1.31接收。 提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Mon Mar 18 10:09:59 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2019-04-05 kexueren

5.789

159 0

[GetPortalCommentsPageByObjectIdResponse(id=588630, encodeId=63795886305e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2020.02.01 submit 2020.03.06 revise 2020.04.02 revision 2020.04.10 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/cbfea1f3df096eb4de0421ec39551f1c.jpg, createdBy=bf172153584, createdName=羽和, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587554, encodeId=9fa758e554e9, content=3-26accepted454646258 2020-03-11 发表:: 刚修回去454646258 2020-03-11 00:00:00 发表: 刚修回去, beContent=454646258 2020-03-11 发表:: 刚修回去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586551, encodeId=70ef586551c6, content=请问二审显示with editor是还没送给reviewer还是已经回来意见了呢Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。Jennyyang 2016-01-22 17:35:00 发表: 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, beContent=Jennyyang 2016-01-22 发表:: 研究方向：甲状腺癌;临床;治疗接收率：约25% 审稿时间：约2个月 SCI(2014)：6.209 刚刚接收了一篇，效率很高，一审一个月零五天（横跨圣诞新年假期），两个审稿人，第一个审稿人1个问题，第二个审稿人5个小问题。二审两天接收。前后不到两个月。课题组今年投了三篇，两篇没审直接秒拒，这篇接收。一般一审了接收率50%，二审了希望就非常大了。一审一个月的时候没给结果，专门发了一封邮件说一个审稿人耽误了，望谅解，会尽快处理。还是很给力的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584398, encodeId=99ee5843988d, content=@454646258，你的结果怎么样了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0988102009, createdName=fangfang424, createdTime=Sat Feb 08 08:53:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582347, encodeId=a69458234e78, content=非常高效，11/12summited；13/12under review；27/12with editor，圣诞节不影响，现在正在等待结果，希望好过！建议认真选好recommended reviewers, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93424732566, createdName=454646258, createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578681, encodeId=2fdc5e868165, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570775, encodeId=920b5e0775cf, content=我2月26投的稿，今天5月11日，依然under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0icicabQPFRfglHZr0mpDfC2oYjwL5n0xDc0wODUNEyWJuia9wXP3TnHwrZMktLMl7OQH7ZoUicGQHiclLb373GdibAg/132, createdBy=b44f2541766, createdName=lucifer11, createdTime=Sat May 11 20:22:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569918, encodeId=a2cb5699187c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这本期刊是内分泌与临床领域的top级别期刊, 很不好投中，但年发文量不低，国内中标率不高，当然编辑觉得不合适，据稿速度也是非常快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ad15083627, createdName=lan2012172_76943970, createdTime=Tue Apr 23 09:56:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569152, encodeId=40445691524c, content=5.789, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3bd1650194, createdName=kexueren, createdTime=Fri Apr 05 08:01:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850297, encodeId=cbde85029ede, content=18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题； 补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。 19.1.31接收。 提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50165414105, createdName=ms5075507494691300, createdTime=Mon Mar 18 10:09:59 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2019-03-18 ms5075507494691300

18.8.27投稿，1个月多一点返回，2个审稿人，大修，提了很专业的问题；
补了几个小实验，回复之后一个审稿人直接通过；另一个非常认真，提了几个小问题，来回两次。
19.1.31接收。
提醒大家一点：彩图收费超级贵！如果没必要用彩图的话，在投稿上传图片的时候就不要用了；否则一旦接受的话，就没办法改了，只能照付。

83 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务